LumiraDx Ltd
NASDAQ:LMDX
LumiraDx Ltd
NASDAQ:LMDX
Price:
0.016 USD
Updated:
May 6, 2024
Section:
Relative Value
The Relative Value of one
LMDX
stock under the Base Case scenario is
0.02
USD.
Compared to the current market price of 0.016 USD,
LumiraDx Ltd
is
Undervalued by 22%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LMDX
Relative Value
Base Case
0.02
USD
Undervaluation 22%
Valuation Multiples
Multiples Across Competitors
LMDX Competitors Multiples
LumiraDx Ltd Competitors
LumiraDx Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
LumiraDx Ltd
NASDAQ:LMDX
|
347.3m USD | 2.7 | -1 | -2.6 | -2.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.4B USD | 4.5 | 32.4 | 19.1 | 28.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.1B USD | 18.5 | 68 | 55.8 | 69.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
123.8B USD | 5.9 | 36.8 | 24 | 29.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.2B USD | 3.3 | 25.8 | 13.7 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.3B USD | 7.2 | 60.2 | 30.7 | 45.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.4B USD | 3.5 | 56.1 | 18.8 | 39.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.5B EUR | 2.7 | 38.6 | 18.5 | 31.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
378.7B CNY | 11 | 33.4 | 29.1 | 29.1 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.3B USD | 13.5 | 80.3 | 60 | 78.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.2B USD | 8.3 | 36.2 | 26.3 | 28.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
